elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34512092-3358A3BB-E5D9-4236-83C5-A3D576B7D0FB
Q34512092-3358A3BB-E5D9-4236-83C5-A3D576B7D0FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34512092-3358A3BB-E5D9-4236-83C5-A3D576B7D0FB
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
P2860
Q34512092-3358A3BB-E5D9-4236-83C5-A3D576B7D0FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34512092-3358A3BB-E5D9-4236-83C5-A3D576B7D0FB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
26d2b5749a4b6ea72976c27d5a76ac363f6a655a
P2860
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan